During the screening of the natural products for their ability to increase the activity of glucokinase by relieving inhibition by long chain fatty acyl CoA esters (FAC), two novel compounds, glucolipsin A (1) and B (2) were isolated from the butanol extracts of 
Streptomyces purpurogeniscleroticus
WC71634and Nocardia vaccinii WC65712, respectively. The structures of these two compounds were established by spectroscopic methods and chemical degradation. One of the principal enzymes of glucose phosphorylation in glucose sensitive cells is glucokinase.
Glucose phosphorylation influences circulating blood glucose levels, making glucokinase regulation one of the principle points for possible therapeutic intervention in diabetes. Long chain fatty acyl CoA esters (FAC) inhibit glucokinase activity allosterically and competitively with respect to glucose in vitro, while glucose itself activates it by a "mnemonic" mechanism1*. The effect of FACin vivo is as yet unknown. Compoundsthat ameliorate the inhibition of glucokinase by its negative allosteric effectors would "activate" the glucokinase activity in the cell. Such "activators" might bind to the fatty acyl CoA esters co factor site or mightsequester these negative effector molecules. Wereport here the discovery of novel compounds exhibiting such novel sequestering activity, thereby appearing to be glucokinase "activating" small molecules.
During the screening of natural products for their ability to relieve the inhibitory effects of stearoyl-CoA on glucokinase, the butanol extracts of Streptomyces purpurogeniscleroticus WC71634and Nocardia vaccinii WC65712were found to be active. When subjected to pp. 245 -255 bioassay-guided fractionation, two novel, closely-related metabolites, designated as glucolipsin A (1) and B (2), were isolated as the major active componentsfrom the butanol extracts Streptomyces purpurogeniscleroticus and Nocardia vaccinii, respectively. The structures of glucolipsin A and B differ from one another only by one methylene group in the side chain. This report describes the fermentative production, isolation, structure elucidation and biological activities of these two compounds. an equal volume of 20% (w/v) glycerol/10% (w/v) sucrose, and aliquots frozen in a dry ice-acetone bath, and stored at -80°C. From the frozen stock, 4ml was used as an inoculum into 100 ml of the vegetative medium described above in a 500ml flask. Both cultures were grown for 3 days at 32°C at 250rpm and then 4ml was used to inoculate 100ml of the production medium in a 500ml flask. The production medium for WC71634, Streptomyces purpurogeniscleroticus, contained the following per liter of distilled water: Japanese potato starch, 15g; fructose, lOg; distillers solubles, 5g; fish meat extract, 2g; MgSO4à"7H2O, 3g; CaCO3, 5g. The production medium of WC65712, Nocardia vaccinii contained the following per liter of distilled water: glycerol, 247 20g; beet molasses, 10g; Pharmamedia, 10g; CaCQ3, 3g. In both cases, the pH was adjusted to 6.5 prior to autoclaving. Both cultures were incubated for 6 days at 32°C at 250rpm.
Materials and Methods

Extraction and Isolation
The isolation and purification procedures of glucolipsin A (1) and B (2) are illustrated in Fig. 2 and Fig.   3 , respectively.
Alkaline Hydrolysis of 1 A 3ml 2%NaOHsolution was added to a solution of 15mg of 1 dissolved in 3ml methanol. The solution was stirred at room temperature for 6 hours. The reaction was monitored by TLC (Si-gel, CH2C12-MeOH-H2O 90 : 10 : 1). The reaction mixture was diluted with water, neutralized to pH 7 with 0.1 n HC1 and evaporated. The aqueous solution was then extracted with w-butanol. The extract was then concentrated in vacuo to dryness and purified by preparative TLC (silica, CH2C12 -MeOH- see Table 2 .
upper layer aqueous fraction Acid Methanolysis of 3 MAR. 1999 A solution of3 (7mg) in 1n HC1-MeOH (3ml) was stirred overnight at room temperature. The reaction was monitored by TLC (Si-gel, CH2C12-MeOH-H2O 90: 10 : 1). The reaction mixture was diluted with water and then extracted with ether. Evaporation of the ethereal extract gave a white amorphous powder of 4 (2mg). 13C-NMR of4: see Table 2 .
Instrumental Analyses
The UVspectrum was taken on a Shimadzu UV2100 spectrophotometer; the IR spectrum was recorded on a Perkin Elmer FT-IR 1800 spectrometer; Electrospray mass spectra (MS) were taken on a Finnigan TSQ7000 triple quadruple mass spectrometer, the high resolution FAB-MSanalysis was performed with a Kratos MS50
mass spectrometer, and all 1H-13C-NMR spectra MgCl2, 50mM D-glucose, and 25mM ATP.
Twoprotocols were used for these assays that differed only in the amount ofFACoxidase and HRPused. When the total amount of FACwas to be estimated, i.e. to check if any FAC had reacted with the compound, the final concentration of FACoxidase was 0.2 units/ml and HRPwas 7.5units/ml. In this protocol, called the end point assay, the reaction was run by adding water, 10 x assay buffer, compound or vehicle and stearoyl-CoA to reaction tubes in the order given. A standard curve was run for stearoyl-CoA (0, 0.5, 1, 2, 3 and 5^m final concentrations). All compounds were tested at 5 and 25 fiM against 2 fiM stearoyl-CoA. Tubes were incubated at 37°C for 15 minute "preincubation". DCFDAwas added with a multipipettor (final concentration 16 /^m).
Enzyme mix (10jA) to give final concentration given above was added to tubes at 15 second intervals. Tubes were sealed and vortexed and placed at 37°C at 15 second intervals so that the incubation times would be constant. After the 15 minutes incubation, tubes were removed, contents placed in cuvettes and absorbance at 502nm
was measured using a Varian Cary 3 spectrophotometer
Since the blanks change with time, the precise incubation period is critical. Compoundswere tested by the same assay for the inhibition ofHRP by using added hydrogen peroxide. Whensimple sequestration was to be tested a kinetic assay measuring the initial rate ofstearoyl CoAoxidation was used. In this assay, called the kinetic assay, the FAC oxidase was reduced to 0.002~0.005 units/ml, while HRP was increased to~1 1 units/ml. These amounts resulted in measurable, reproducible rates. The assay is run exactly as the earlier assay up until the preincubation step. After this step, the reaction mix is transferred to a cuvette, HRP and DCFDAadded, and the mix incubated in the spectrophotometer at 37°C to obtain a stable blank rate. FAC oxidase is finally added and the rate of change of absorbance at 502nm monitored for 3 minutes. Rates were calculated after subtraction of the blank rate. The percent ratio of the rate in presence of compoundto the rate in the absence of compound was used as % inhibition.
Results and Discussion
Isolation
The fractionation of the fermentation broths of Streptomyces purpurogeniscleroticus WC71634 and Nocardia vaccinii WC651\2were monitored by the glucokinase activation assay, and the detailed procedures are illustrated in Fig. 2 and Fig. 3 Someimportant physico-chemical properties of these two compounds are summarized in Table 1 . The XH-and 13C-NMRspectra of glucolipsin A, which are almost identical to those ofglucolipsin B, are reproduced in Fig.   4 ,5.
Structure Elucidation Glucolipsin A: (1) High resolution FABMS analysis revealed that 1 has a molecular formula of C50H92O14, with 5 degrees of unsaturation. The IR spectrum showedabsorption bands at 3364 and 1734cm"1, which are characteristic of hydroxyl and ester groups. The presence of an ester carbonyl group was confirmed by the 13C-signal at S 175.7in the 13C-NMRspectrum. The JH-and 13C-NMR spectra further revealed the presence of a sugar moiety and a fatty acid fragment. Furthermore, three methyl groups, one oxymethine, two methines and a numberof methylene groups (around twelve) in the fatty acid portion were readily indicated. The signals arising from these methylene groups were heavily overlapped in both 1H-, and 13C-NMR spectra. The above mentioned structural fragments were accounted for only about half of its molecular weight, thus, the compound should be Details of the assay and rationale are described under Methods.
C-6' was substituted.
There appeared to be more than one possible connection between the two identical glucosyl moieties and the two identical fatty acid portions. However, taking into account the fact that there was only one remaining degree of unsaturation, the connection between sugar and fatty acid moieties in this structure can be only proposed as shownin Fig. 1 . The connectivities among C-l ester carbonyl (3C 175.7), C-2 methine (Sc 46.6, 8U 2.63), C-3 oxymethine (Sc 78.9, SH 4.07) and C-l9 methyl ((5C 13.4, SH 1.31) of each hydroxyl fatty acid fragments were clearly suggested by their proton spin systems and confirmed by the HMBCcorrelations (Fig. 6 ) between the related carbons and protons. The attachment of the long fatty chain to C-3 oxymethine was indicated by the proton coupling between H-3 and the methylene protons arising from the fatty chain. Each of the two fatty chains should be composed of the remaining functional groups:
two methyl groups, one methine and 12 methylene groups, which could be easily deduced from its molecular weight or formula. The two methyl groups (C-l7, Sc 14. HMBC correlations between C-16 and the protons of the methyl groups as well as between C-18 and 17-H, also between C-17 and 18-H. In order to confirm the proposed structure, chemical degradation studies (saponification and acid methanolysis) (Fig. 7) were carried out. The spectral data of the degradation products were analysed. Uponsaponification, 1 afforded the monomer3. Acidic methanolysis of 3 yielded 4. The structure of compound 3 was confirmed by their spectral data. The 1H-, 13C-NMRspectra of 3 were similar to those of1 except the signals ofC-6', H-6a' and H-6b'. Compared to the corresponding signals of compound 1, the signals of C-6' was shifted to up field to 62.8, and the signals ofH-6a' and H-6b' were shifted also up field and appeared as two double doublets at 3.82 and 3.70, respectively. These changes suggested that the C-6 of the glucosyl moiety should bear a free hydroxyl group. The structure of compound4 was confirmed by Glucolipsin A was further tested in the secondary assay, glucolipsin A did not modify stearoyl CoA, since preincubation of the compounddid not result in any change in stearoyl CoAlevels as measured by an enzymatic assay. However, the compound did appear to deplete the free concentration of stearoyl CoAsince the rate of stearoyl 
